InBody Co.,Ltd (041830.KQ)

KRW 21950.0

(-1.13%)

Long Term Debt Summary of InBody Co.,Ltd

InBody Co.,Ltd's latest annual long term debt in 2023 was 3.63 Billion KRW , down -15.47% from previous year.
InBody Co.,Ltd's latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
InBody Co.,Ltd reported annual long term debt of 4.3 Billion KRW in 2022, up 134.88% from previous year.
InBody Co.,Ltd reported annual long term debt of 1.83 Billion KRW in 2021, down -34.83% from previous year.
InBody Co.,Ltd reported quarterly long term debt of 4.3 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
InBody Co.,Ltd reported quarterly long term debt of 3.63 Billion KRW for 2023 Q4, down -17.46% from previous quarter.

Annual Long Term Debt Chart of InBody Co.,Ltd (2023 - 2012)

Historical Annual Long Term Debt of InBody Co.,Ltd (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	3.63 Billion KRW	-15.47%
2022	4.3 Billion KRW	134.88%
2021	1.83 Billion KRW	-34.83%
2020	2.8 Billion KRW	9.71%
2019	2.56 Billion KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%
2014	- KRW	0.0%
2013	- KRW	0.0%
2012	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- KRW	0.0%
2024 Q1	4.3 Billion KRW	0.0%
2023 Q4	3.63 Billion KRW	-17.46%
2023 FY	3.63 Billion KRW	-15.47%
2023 Q1	4.08 Billion KRW	-4.94%
2023 Q2	3.87 Billion KRW	-5.29%
2023 Q3	4.4 Billion KRW	13.75%
2022 FY	4.3 Billion KRW	134.88%
2022 Q4	4.3 Billion KRW	151.66%
2022 Q3	1.7 Billion KRW	-9.44%
2022 Q2	1.88 Billion KRW	10.69%
2022 Q1	1.7 Billion KRW	-6.9%
2021 Q1	2.48 Billion KRW	-11.47%
2021 Q3	2.1 Billion KRW	-12.23%
2021 Q4	1.83 Billion KRW	-12.88%
2021 Q2	2.39 Billion KRW	-3.72%
2021 FY	1.83 Billion KRW	-34.83%
2020 Q2	3.28 Billion KRW	0.0%
2020 FY	2.8 Billion KRW	9.71%
2020 Q3	3.47 Billion KRW	5.78%
2020 Q1	- KRW	-100.0%
2020 Q4	2.8 Billion KRW	-19.23%
2019 Q4	2.56 Billion KRW	13.26%
2019 FY	2.56 Billion KRW	0.0%
2019 Q3	2.26 Billion KRW	0.0%
2019 Q2	- KRW	0.0%
2019 Q1	- KRW	0.0%
2018 Q1	- KRW	0.0%
2018 Q4	- KRW	0.0%
2018 FY	- KRW	0.0%
2018 Q2	- KRW	0.0%
2018 Q3	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q4	- KRW	0.0%
2017 Q3	- KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q2	- KRW	0.0%
2016 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2016 Q2	- KRW	0.0%
2016 Q1	- KRW	0.0%
2016 Q3	- KRW	0.0%
2015 Q3	- KRW	0.0%
2015 Q1	- KRW	0.0%
2015 FY	- KRW	0.0%
2015 Q4	- KRW	0.0%
2015 Q2	- KRW	0.0%
2014 Q3	- KRW	0.0%
2014 Q4	- KRW	0.0%
2014 Q2	- KRW	0.0%
2014 Q1	- KRW	0.0%
2014 FY	- KRW	0.0%
2013 Q2	- KRW	0.0%
2013 Q4	- KRW	0.0%
2013 FY	- KRW	0.0%
2013 Q1	- KRW	0.0%
2013 Q3	- KRW	0.0%
2012 Q3	- KRW	0.0%
2012 FY	- KRW	0.0%
2012 Q4	- KRW	0.0%

Peer Long Term Debt Comparison of InBody Co.,Ltd

Name	Long Term Debt	Long Term Debt Difference
Osang Healthcare Co.,Ltd	367.49 Million KRW	-889.46%
Curexo Inc.	1.48 Billion KRW	-144.343%
Seegene, Inc.	1.42 Billion KRW	-155.452%
i-SENS, Inc.	45.74 Billion KRW	92.052%
Ray Co., Ltd.	155.4 Million KRW	-2239.878%
Gencurix Inc.	5.47 Billion KRW	33.599%
Sugentech Inc.	240 Million KRW	-1415.071%
L&C Bio Co., Ltd	541.32 Million KRW	-571.723%